View More Recent Stories

May 12, 2017 05:00PM Acerus Reports First Quarter 2017 Financial Results
May 8, 2017 05:00PM Acerus to Report First Quarter 2017 Financial Results and Host Investor Call
May 5, 2017 07:00AM Acerus Announces Appointment of Ken Yoon as Chief Financial Officer
Apr 24, 2017 07:00AM Acerus to Present at the 2017 Bloom Burton & Co. Healthcare Investor Conference
Apr 5, 2017 05:00PM Acerus Announces NATESTO® Regulatory Filing in South Korea
Mar 8, 2017 07:00AM Acerus Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 1, 2017 07:30AM Acerus Files a New Drug Submission for GYNOFLOR™ in Canada
Feb 28, 2017 05:00PM Acerus to Report 2016 Financial Results and Host Investor Call
Feb 8, 2017 05:00PM Acerus Announces NATESTO® Posters to Be Presented at the Endocrine Society 2017 Annual Meeting
Jan 24, 2017 07:30PM ACERUS ANNOUNCES NATESTO® ABSTRACTS TO BE PRESENTED AT THE AMERICAN UROLOGICAL ASSOCIATION’S ANNUAL MEETING
Jan 9, 2017 07:30AM Acerus Announces Completion of Loan Repayment
Dec 21, 2016 10:00PM Acerus Comments on Decision Regarding Litigation
Dec 15, 2016 05:30PM Acerus Announces NATESTO® License Agreement with Hyundai Pharm
Nov 2, 2016 07:00AM Acerus Reports Third Quarter 2016 Financial Results
Nov 1, 2016 07:30AM Acerus Announces Appointment of Tricia Symmes as Chief Operating Officer
Oct 26, 2016 07:30AM Acerus to Announce Third Quarter 2016 Financial Results on November 2, 2016
Oct 5, 2016 05:30PM Acerus Announces Canadian Commercial Launch of NATESTOTM
Aug 24, 2016 02:00PM Acerus Comments on Trading Activity
Aug 9, 2016 07:00AM Acerus Reports Second Quarter 2016 Results
Aug 2, 2016 07:00AM Acerus to Announce Second Quarter 2016 Results on August 9, 2016
Jul 21, 2016 07:00AM Acerus Appoints Mr. Luc Mainville to Its Board of Directors
Jul 6, 2016 07:00AM Acerus Completes NATESTO® U.S. Transition
Jun 20, 2016 11:15PM Acerus Announces Voting Results for the 2016 Annual General Meeting
Jun 17, 2016 07:00AM Acerus Announces NATESTO™ Scientific Abstract Presentation at the 71St Annual Canadian Urological Association Meeting
May 17, 2016 07:00AM Acerus Provides Update on Litigation
May 4, 2016 07:00AM Acerus Reports First Quarter 2016 Results and Provides Business Update
Apr 27, 2016 05:20PM Acerus Completes Private Placement of Common Shares
Apr 27, 2016 07:00AM Acerus to Announce First Quarter 2016 Financial and Operating Results on May 4, 2016
Apr 25, 2016 05:00PM Acerus to Present at the 2016 Bloom Burton & Co. Healthcare Investor Conference
Apr 25, 2016 07:45AM Acerus Announces U.S. License Agreement for NATESTO®
Apr 18, 2016 07:00AM Acerus Acquires Canadian Rights to GYNOFLOR™
Apr 8, 2016 07:00AM Acerus Comments on Statement of Claim
Apr 4, 2016 05:05PM CORRECTING and REPLACING: Acerus Announces Departure of Dr. Michael Bumby
Mar 28, 2016 02:22PM Acerus Comments on Trading Activity
Mar 8, 2016 10:02PM Acerus Comments on Notice of Action
Mar 2, 2016 07:00AM Acerus Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 24, 2016 07:00AM Acerus to Report 2015 Financial Results and Host Investor Call
Jan 7, 2016 04:05PM Amer Strategic Inc Portfolio (ASP) Announces Health Canada Approval For NATESTO
Jan 7, 2016 04:04PM Acerus Receives Health Canada Approval For NATESTO™
Jan 4, 2016 07:00AM Acerus Announces NATESTO™ Publication in Prominent Andrology Journal
Dec 31, 2015 07:02AM Acerus Pharmaceuticals Terminates U.S. NATESTO Deal with Endo (ENDP)
Dec 31, 2015 07:00AM Acerus Announces Termination of NATESTO™ Agreement with Endo
Dec 21, 2015 06:00AM Acerus Announces Changes to Board of Directors
Dec 11, 2015 05:06PM Acerus Announces Amendment to Loan Agreement
Nov 20, 2015 07:00AM Acerus Reports Approval of ESTRACE® Generic in Canada
Nov 5, 2015 06:30AM Acerus Provides Business Update and Announces Third Quarter 2015 Financial Results
Oct 30, 2015 07:00AM Acerus to Report Third Quarter 2015 Results and Host Investor Call
View More Recent Stories